- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04316858
Randomized Trial Comparing Carbonated Drink With Water as a Solvent for Colonoscopy Solution
A Prospective Randomized Trial in Comparison of Zero Calorie Carbonated Drink or Water as a Solvent in Sodium Phosphate for Colonoscopy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This prospective randomized trial will be conducted in all patients undergoing elective colonoscopies from February 2020 to August 2020 in Dowites Operation Theater Endoscopy suite by surgical unit III, Civil Hospital Karachi. Patient will be select randomly based on inclusion criteria. Patients will be advised to take 90ml of sodium phosphate in 800ml solvent ( zero calorie soft drink and water). Patients will be nil per oral from midnight aside from clear liquids. Serum electrolytes, urea, creatinine will be measured after and before bowel preparation. Bowel preparation will be assessed by consultant during endoscopy. Questionnaire will be filled by PI for palatability, tolerance of solution, adverse effects, and willingness to repeat the preparation.
90ml of sodium phosphate will be added to 800ml of solvent and taken in divided doses one day prior to procedure. Whole solution will be finished 3 -4 hours before colonoscopy. The instructions about how to take the solution will be clearly explained at the time of booking. Complete Blood Count and hepatitis B and C screening as routine shall be done. All procedure will be carried out under monitored sedation by trained colorectal surgeon from the faculty
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Sindh
-
Karachi, Sindh, Pakistan, 71000
- Dow University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
• Age > 18 years
- Non-emergency / non urgent colorectal diseases (IBD, suspected colonic polyps, colorectal cancer)
- Screening Colonoscopy
Exclusion Criteria:
- Age <18 years Pregnancy Intestinal obstruction Unfit patient Acute or serious illness Coagulopathy Unwilling patients
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Water
Water will be used as solvent for sodium phosphate
|
90ml of sodium phosphate will be added to 800ml of solvent( water or zero calorie carbonated drink) and taken in divided doses one day prior to procedure.
Whole solution will be finished 3 -4 hours before colonoscopy.
Other Names:
800 ml of water will be added to 90 ml of sodium phosphate to facilitate its intake by the patients preparatory to colonoscopy
|
|
Active Comparator: Zero calorie carbonated drink
Zero calorie carbonated drink will be used as solvent for sodium phosphate
|
90ml of sodium phosphate will be added to 800ml of solvent( water or zero calorie carbonated drink) and taken in divided doses one day prior to procedure.
Whole solution will be finished 3 -4 hours before colonoscopy.
Other Names:
800 ml of zero calorie diet cola will be added to 90 ml of sodium phosphate to facilitate its intake by the patients preparatory to colonoscopy
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Palatability of the solution including willingness to repeat the preparation
Time Frame: This will be collected at the procedure appointment which is expected to be 2-3 hours in length. This time will be labelled as time 0 and will be noted once. T
|
This will be assessed by a questionnaire to be filled by the patient on check-in for the colonoscopy procedure.
It will be scored on a scale of 1 to 4 as excellent, good, satisfactory or bad; score 1 being excellent result.
|
This will be collected at the procedure appointment which is expected to be 2-3 hours in length. This time will be labelled as time 0 and will be noted once. T
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Degree of bowel cleanliness.
Time Frame: This will be collected at the procedure appointment which is expected to be 2-3 hours in length.
|
This will be assessed by a questionnaire to be filled by the endoscopist after completion of endoscopy.
It will assessed on a scale of 1 to 4 as excellent, satisfactory, poor or bad, with score 1 being the excellent.
|
This will be collected at the procedure appointment which is expected to be 2-3 hours in length.
|
|
Incidence of adverse effects.
Time Frame: This will be collected at the procedure appointment which is expected to be 2-3 hours in length. It will be noted once.
|
This will be assessed by the reporting of adverse effects by the patients and laboratory evaluation of electrolytes prior to and after bowel preparation.
These will be noted on a proforma and following side effects will be noted: Nausea/vomiting, bloating, cramps, or electrolyte abnormalities.
|
This will be collected at the procedure appointment which is expected to be 2-3 hours in length. It will be noted once.
|
|
Completion time of preparation.
Time Frame: This will be assessed only once on check-in for the colonoscopy procedure.This will be collected at the procedure appointment which is expected to be 2-3 hours in length.
|
This will be assessed in minutes on check-in for the colonoscopy procedure.
|
This will be assessed only once on check-in for the colonoscopy procedure.This will be collected at the procedure appointment which is expected to be 2-3 hours in length.
|
Collaborators and Investigators
Investigators
- Principal Investigator: hina noman, fcps, dow university and health sciences
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- HNoman
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colonoscopy
-
Borland-Groover ClinicValley Medical Products, LLC is paying for the study and is the sponsor....CompletedColonoscopy | Screening Colonoscopy | Surveillance ColonoscopyUnited States
-
Eastern Mediterranean UniversityNot yet recruitingColonoscopy | Colonoscopy Preparation | Colonoscopy Preparation Outcome | Colonoscopy Diagnostic Techniques and Procedures
-
Josue AliagaCompleted
-
Endostart srlCompleted
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityCangzhou Central Hospital; Guangdong Second Provincial General Hospital; Tianjin... and other collaboratorsNot yet recruitingColonoscopy | Bowel Preparation for Colonoscopy
-
Rambam Health Care CampusUnknownInadequate Preparation for Colonoscopy; Personalized Colonoscopy PreparationIsrael
-
Hospital Central Norte PEMEXCompletedPerformance of Colonoscopy | Tolerance of ColonoscopyMexico
-
VA Office of Research and DevelopmentVA Palo Alto Health Care System; VA Northern California Health Care SystemCompletedWater Exchange Colonoscopy | Unsedated Colonoscopy | Cap | Colonoscopy PainUnited States
-
Dalin Tzu Chi General HospitalCompletedColonoscopy | Intubation Time | Cap-assisted ColonoscopyTaiwan
-
Valduce HospitalCompletedUnsedated Colonoscopy | Warm Water | CO2 ColonoscopyItaly
Clinical Trials on Sodium phosphate
-
Union Hospital, Tongji Medical College, Huazhong...Recruiting
-
University of Texas Southwestern Medical CenterRecruitingPhysical Inactivity | Visceral Obesity | Phosphate OverloadUnited States
-
Laboratoires Mayoly SpindlerCompleted
-
University of North Carolina, Chapel HillCompletedLaparoscopic Hysterectomy and/or Laparoscopic SacrocolpopexyUnited States
-
TheiaNova Ltd.Enrolling by invitation
-
Fundación SalutiaTecnoquimicas S.AUnknown
-
Universal Integrated Corp.Completed
-
Semnur Pharmaceuticals, Inc.Cromos Pharma LLC; SyngeneNot yet recruitingLumbosacral Radicular Pain
-
HaEmek Medical Center, IsraelWithdrawnComparison of 2 Doses of Corticosteroid Subacromial Injections for the Treatment of Painful ShoulderBursitis | TendonitisIsrael
-
Ayman Anis MetryCompletedEffect of Hypophosphatemia on Septic PatientsEgypt